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The transcription factor cAMP response element modu-
lator (CREM) is a widely expressed transcriptional
repressor which is important for the termination of the
T cell immune response. CREMa is overexpressed in
SLE (Systemic lupus erythematosus) T cells and is sup-
posed to be a key player in orchestrating the transcrip-
tional program of SLE T cells by targeting T cell-
relevant genes. To explore the relevance of CREMa in
vivo we used a well-established murine lupus model,
which is characterized by the introduction of a mutation
in the CD95 (Fas) locus. We generated a transgenic
mouse with a selective overexpression of CREMa in T
cells and introduced a Fas -/- phenotype into the
CREMa transgenic mice. CREMa transgenic Fas -/-
mice developed a severe lymphadenopathy and spleno-
megaly as early as 8 weeks of age, while the wildytpe
Fas -/- mice did not at this early age. Lymphadenopathy
and splenomegaly is paralleled by a massive expansion
of pathogenic CD3+CD4-CD8- double negative T cells.
Furthermore T cells of CREMa transgenic Fas -/- mice
show an enhanced production of IL-21 and IL-17,
which are hallmark cytokines of highly inflammatory
Th17 cells. Vice versa percentages of regulatory T cells
are reduced. The enhanced occurrence of aberrant and
inflammatory T cells further leads to increased B cell
activation, increased anti-DNA antibody titers and
finally shortened life expectation of these mice.
Our experiments are the proof of principle for a criti-
cal amplifying role of CREMa in autoimmune prone
conditions like SLE.
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